Activation of Ras/MAPK and mTOR pathways in hepatocellular carcinoma: Tumor growth inhibition with Ras/mTOR pathway abrogation by a novel combination of Sorafenib and rapamycin
2007 ◽
Vol 205
(3)
◽
pp. S93-S94
Keyword(s):
2012 ◽
Vol 138
(11)
◽
pp. 1879-1890
◽
2011 ◽
Keyword(s):
2010 ◽
Vol 38
(9)
◽
pp. 1436-1442
◽